ORL1 receptor ligands:: Structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones

被引：27
|
作者：
Röver, S [1 ]
Wichmann, J [1 ]
Jenck, F [1 ]
Adam, G [1 ]
Cesura, AM [1 ]
机构：
[1] F Hoffmann La Roche Ltd, PRBC, Div Pharma, CH-4070 Basel, Switzerland
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2000年 / 10卷 / 08期
关键词：
D O I：
10.1016/S0960-894X(00)00111-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We have investigated 5-cycloalkyl-1-phenyl-1,3,8-triaza-spirol4.5ldecan-4-ones as ligands for the ORL1 receptor. These unsophisticated, achiral compounds show remarkable affinity for the ORL1 receptor. Optimizing for selectivity we show that the maximum of affinity and selectivity versus the other opioid receptors is achieved for 8-cyclodecyl-1-phenyl-1,3,8-triaza-spiro-[4.5] decan-4-one 2e and 8-(cis-4-isopropyl-cyclohexyl)-1-phenyl- 1,3,8 -triaza-spiro[4.5]decan-4-one 2q. The identified compounds (2e, 2q) are more or less equipotent to the natural ligand itself, both in the binding assay and in the functional GTP gamma S assay. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：831 / 834
页数：4
相关论文
共 50 条
  • [1] 8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists
    Wichmann, J
    Adam, G
    Röver, S
    Cesura, AM
    Dautzenberg, FM
    Jenck, F
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2343 - 2348
  • [2] Synthesis and structure-activity relationships of aminoalkylazetidines as ORL1 receptor ligands
    Wu, WL
    Caplen, MA
    Domalski, MS
    Zhang, HT
    Fawzi, A
    Burnett, DA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3157 - 3160
  • [3] 8-[4-(4-FLUOROPHENYL)-3-PENTENYL]-1-PHENYL-1,3,8-TRIAZA-SPIRO[4,5]DECAN-4-ONE(SPIRILENE)
    KOCH, MHJ
    EVRARD, G
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1973, 29 (DEC15): : 2971 - 2973
  • [4] (8-naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]-dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist
    Thomsen, C
    Hohlweg, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (05) : 903 - 908
  • [5] Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties
    Wichmann, J
    Adam, G
    Röver, S
    Hennig, M
    Scalone, M
    Cesura, AM
    Dautzenberg, FM
    Jenck, F
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (09) : 839 - 851
  • [6] EXAMINATION OF A SERIES OF 8-[3-[BIS(4-FLUOROPHENYL)AMINO]PROPYL]-1-ARYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONES AS POTENTIAL ANTIPSYCHOTIC AGENTS
    WISE, LD
    PATTISON, IC
    BUTLER, DE
    DEWALD, HA
    LEWIS, EP
    LOBBESTAEL, SJ
    TECLE, H
    COUGHENOUR, LL
    DOWNS, DA
    POSCHEL, BPH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (12) : 1811 - 1817
  • [7] The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a μ, κ, and δ opioid receptor agonist cue
    Recker, MD
    Higgins, GA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (02): : 652 - 658
  • [8] Discovery and structure-activity relationships of 4-aminoquinazoline derivatives, a novel class of opioid receptor like-1 (ORL1) antagonists
    Okano, Masahiko
    Mito, Jun
    Maruyama, Yasufumi
    Masuda, Hirofumi
    Niwa, Tomoko
    Nakagawa, Shin-ichiro
    Nakamura, Yoshitaka
    Matsuura, Akira
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (01) : 119 - 132
  • [9] Ro 64-6198 [(1S, 3aS)-8-(2,3,3a, 4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices
    Chiou, LC
    Chuang, KC
    Wichmann, J
    Adam, G
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (02): : 645 - 651
  • [10] 1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity
    Guillon, Jean
    Savrimoutou, Solene
    Rubio, Sandra
    Moreau, Stephane
    Pinaud, Noel
    Marchivie, Mathieu
    Desplat, Vanessa
    [J]. MOLBANK, 2020, 2020 (01)
12345